Anti-Human PD-L1 (CD274) (Clone 29E.2A3) - Dylight® 594

Catalogue Number: P608-LET

Manufacturer:	Leinco Technologies, Inc
Type:	Monoclonal Primary Antibody - Conjugated
Shipping Condition:	Blue Ice
Unit(s):	100 ug, 25 ug, 500 ug
Host name:
Clone:	29E.2A3
Isotype:
Immunogen:
Application:	FC

Overview

Description

Description: Programmed cell death 1 ligand 1 (PD-L1; CD274; B7-H1) is a type I transmembrane glycoprotein widely expressed in many types of tissues that acts as a ligand for the immune inhibitory receptor programmed cell death 1 (PD-1; CD279)1, 2, 3. The PD-1 pathway is responsible for T cell activation, proliferation, and cytotoxic secretion, with PD-1/PD-L1 interaction triggering inhibitory signals that dampen T cell function. PD-L1 also plays a critical role in the differentiation of inducible regulatory T cells4. In normal tissues, PD-L1/PD-1 ligation is crucial to maintaining homeostasis of the immune system and preventing autoimmunity during infection and inflammation4. In the tumor microenvironment, their interaction provides an immune escape mechanism for tumor cells by turning off cytotoxic T cells. As such, blocking the PD-L1/PD-1 interaction is a target of many anti-cancer immunotherapies. 29E.2A3 was generated by immunizing female BALB/c mice with purified hPD-L1 cDNA5. Spleen cells were fused with SP2/0 myeloma cells, and the resulting hybridomas were screened by ELISA for reactivity against hPD-L1-Ig fusion protein followed by cell-surface staining of hPD-L1-transfected Chinese hamster ovary cells and 300.19 cells.

Additional Text

Concentration

0.2 mg/ml

Antibody Clonality

Monoclonal

Storage Note

This DyLight® 594 conjugate is stable when stored at 2-8°C. Do not freeze.

Price

£229.00

-

Quantity
Unit Size

Find out about delivery